Clinical observation of the painless dressing change effectof esketamine combined with dexmedetomidine in burn patients

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000032305

Enrollment

Unknown

Registered

2020-04-25

Start date

2020-05-01

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

burn patients

Interventions

GROUP1:Perioperative use esketamine combined with dexmedetomidine

GROUP2:Perioperative use 0.9% Physiolodical saline solution

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20-70 years; 2. Female/ Male 3. Body mass index 18-26kg/M2; 4. ASA I-III; 5. Patients voluntarily participate in the trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe coagulation dysfunction; 2. History of chronic pain and long-term use of opioids or NSAIDs; 3. Allergy to anesthetic involved in this study; 4. Serious cardiovascular and cerebrovascular diseases, liver, kidney and blood system dysfunction.

Design outcomes

Primary

Measure	Time frame
MAP;HR;RR;Spo2;	—

Secondary

Measure	Time frame
VAS score;	—

Countries

China

Contacts

Public ContactXu Weimin

Shengli Oilfeild Central Hospital

xuweimin2002@sina.com+86 13589994561

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026